Published 6h ago2026-04-10 07:29:47

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

-- Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)